Price Alert

Bausch + Lomb Corporation (BLCO)

NYSE: BLCO · Real-Time Price · USD

15.02

-0.06 (-0.40%)

At close: Sep 24, 2025, 3:59 PM

15.01

-0.07%

After-hours: Sep 24, 2025, 06:26 PM EDT

-0.40% (1D)

Bid	14.9
Market Cap	5.32B
Revenue (ttm)	4.89B
Net Income (ttm)	-401M
EPS (ttm)	-0.78
PE Ratio (ttm)	-19.26
Forward PE	19.33
Analyst	Hold
Dividends	n/a

Ask	15.36
Volume	377,605
Avg. Volume (20D)	754,471
Open	15.04
Previous Close	15.08
Day's Range	15.01 - 15.29
52-Week Range	10.45 - 21.69
Beta	0.63
Ex-Dividend Date	n/a

About BLCO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BLCO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BLCO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Bausch + Lomb Corporation is scheduled to release its earnings on Oct 29, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

-15.74%

Bausch + Lomb shares are trading lower after the c... Unlock content with Pro Subscription

7 months ago

-9.52%

Bausch + Lomb shares are trading lower after the company announced that the process of going private will not result in a transaction at this time. Also, the company announced that the process to complete a full separation did not lead to an offer that reflected its value.

News

2 weeks ago · seekingalpha.com

Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Bausch + Lomb Corporation (NYSE:BLCO ) Bausch + Lomb Corporation Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:45 AM EDT Company Participants Brenton L. Saunders - CEO & ...

1 month ago · businesswire.com

Bausch + Lomb Announces Board Changes

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Amend...

Bausch + Lomb Corporation (NYSE:BLCO ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Brenton L. Saunders - CEO & Chairman George Gadkowski - Corporate Participant Osam...

1 month ago · zacks.com

Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Bausch + Lomb (BLCO) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall St...

1 month ago · zacks.com

Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.13 per share a year ago.